198 related articles for article (PubMed ID: 18472359)
1. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma.
Shinohara ET; Mitra N; Guo M; Metz JM
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1495-501. PubMed ID: 18472359
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.
Shinohara ET; Mitra N; Guo M; Metz JM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1191-8. PubMed ID: 19201549
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
4. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy in the treatment of cholangiocarcinoma.
Shinohara ET; Guo M; Mitra N; Metz JM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.
Fuller CD; Wang SJ; Choi M; Czito BG; Cornell J; Welzel TM; McGlynn KA; Luh JY; Thomas CR
Cancer; 2009 Nov; 115(22):5175-83. PubMed ID: 19637356
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
11. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.
Sagawa N; Kondo S; Morikawa T; Okushiba S; Katoh H
Surg Today; 2005; 35(7):548-52. PubMed ID: 15976951
[TBL] [Abstract][Full Text] [Related]
13. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
14. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.
Pitt HA; Nakeeb A; Abrams RA; Coleman J; Piantadosi S; Yeo CJ; Lillemore KD; Cameron JL
Ann Surg; 1995 Jun; 221(6):788-97; discussion 797-8. PubMed ID: 7794082
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis.
Shridhar R; Blinn P; Huston J; Meredith KL
Cancer; 2023 Mar; 129(6):890-900. PubMed ID: 36544387
[TBL] [Abstract][Full Text] [Related]
16. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
18. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
[TBL] [Abstract][Full Text] [Related]
19. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review.
Wang ML; Ke ZY; Yin S; Liu CH; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):110-116. PubMed ID: 30470543
[TBL] [Abstract][Full Text] [Related]
20. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
